Mouse Wound Model
Mouse Wound Model - Related Videos
04:03
Mouse Wound Models and Preparation of Single-Cell Suspensions
0 Views •
Cited by 1 •
2024
This study presents two crucial experimental techniques: the construction of a murine wound model for assessing wound closure and the preparation of single-cell suspensions from murine skin to preserve cellular viability.
07:16
Swine Model of Biofilm Infection and Invisible Wounds
0 Views •
Cited by 12 •
2023
Chronic wounds that are resistant to antibiotics are a major threat to the healthcare system. Biofilm infections are stubborn and hostile and can cause deficient functional wound closure. We report a clinically relevant swine model of biofilm-infected full-thickness chronic wounds. This model is powerful for mechanistic studies as well as for testing interventions.
09:20
A Mouse Fetal Skin Model of Scarless Wound Repair
0 Views •
Cited by 24 •
2015
During mammalian development, early gestational skin wounds heal without a scar. Here we detail a reliable and reproducible model of fetal scarless wound healing in the cutaneous dorsum of E16.5 (scarless) and E18.5 (scarring) mouse embryos.
08:35
Demonstration of the Rat Ischemic Skin Wound Model
0 Views •
Cited by 32 •
2015
The rat, due to its size, availability, and rather docile behavior, has been utilized as a research model for many years. The goal of this protocol is to utilize the rat as an ischemic skin wound healing model to provide valuable insight into the pathophysiology of chronic wounds.
07:56
Digital Planimetry for Assessing Wound Closure Kinetics in a Mouse Model
0 Views •
Cited by 2 •
2025
Wounds represent a global health challenge. This study developed a standardized photo booth utilizing digital planimetry to minimize wound measurement variability. Monitoring wounds in mice over 14 days revealed an initial increase in wound area and perimeter, followed by gradual closure. This methodology may aid in evaluating wound closure kinetics in pre-clinical models.
FAQs
The ordered progression from hemostasis and inflammation to tissue formation and remodeling provides a framework for locating when a treatment acts. Early measurements can indicate effects on inflammatory repair, whereas later assessments reveal changes in tissue formation, vascularization, or remodeling. This timing helps distinguish a material that accelerates closure from one that improves the quality of regenerated tissue.
Outcomes reflect interactions among wound-healing cells, signaling pathways, therapeutic materials, drug-delivery systems, and engineered scaffolds. Changing the material or construct can alter how repair proceeds and can produce differences in closure, re-epithelialization, vascularization, or tissue quality. Controlled injuries allow these factors to be compared systematically rather than evaluated only through uncontrolled changes in wound appearance.
Because the model places a material or scaffold within a living repair response, it can reveal how the intervention interacts with coordinated cellular and signaling processes. This provides information that isolated testing may not capture, including effects on closure, new epithelial coverage, vascularization, and tissue quality. The resulting evidence supports comparison of candidate designs during preclinical development.
A study begins by creating a controlled skin injury, followed by applying or evaluating a selected dressing, drug-delivery system, or tissue-engineered construct. Researchers then monitor repair across the healing process and assess defined outcomes such as closure, re-epithelialization, vascularization, and tissue quality. Comparing treated and control conditions helps attribute differences to the tested intervention.
Wound closure provides a broad measure of repair progress, while re-epithelialization indicates restoration of the skin surface. Vascularization helps evaluate blood-vessel development, and tissue-quality assessments address the character of the repaired region rather than its size alone. Considering these outcomes together gives a more complete interpretation of whether a dressing, delivery system, or scaffold improves healing.
The model connects engineered design with biological performance by allowing researchers to test materials, delivery systems, and scaffolds during tissue repair. It can support mechanistic studies of signaling and cellular responses while also providing preclinical evidence for candidate therapies. However, findings require careful interpretation because biological differences between mice and humans can affect translation to human treatment.